QTTB

Q32 Bio Inc

Price

$8.10

return (12m)

126.89%

p/e

4.90

p/bv

1.56

DIVIDEND YIELD

0.00%

QTTB price

Q32 Bio Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment QTTB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-27.30%

3 months

-56.12%

1 year

126.89%

2 years

-82.50%

5 years

-92.73%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals QTTB

Valuation

P/E

4.90

Sector 7.77

Industry 7.77

P/BV

1.56

Sector 1.72

Industry 1.72

P/Revenue (PSR)

Sector 1.69

Industry 1.69

EV/EBITDA

-6.57

Sector -5,068.50

Industry -5,068.50

EV/EBIT

-6.51

Sector -17,869.22

Industry -17,869.22

P/EBITDA

4.82

Sector -12.84

Industry -12.84

P/EBIT

4.87

Sector -10.90

Industry -10.90

P/Total Assets

1.43

Sector 0.81

Industry 0.81

P/Net Current Assets

1.66

Sector -1.83

Industry -1.83

P/Working Capital

1.59

Sector -19.82

Industry -19.82

EPS

1.66

Sector 0.71

Industry 0.71

BVPS

5.21

Sector 9.79

Industry 9.79

Efficiency

Gross Margin

0.00%

Sector 35.82%

Industry 35.82%

EBITDA Margin

Sector -189.31%

Industry -189.31%

EBIT Margin

0.00%

Sector 4.44%

Industry 4.44%

Net Profit Margins

0.00%

Sector 2.53%

Industry 2.53%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

31.90%

Sector 2.52%

Industry 2.52%

ROA

29.16%

Sector -0.67%

Industry -0.67%

ROIC

-318.69%

Sector -120.09%

Industry -120.09%

Dividends

Dividend yield

0.00%

Sector 0.53%

Industry 0.53%

Payout

0.00%

Sector 9.99%

Industry 9.99%

Debt

Current Ratio

20.30

Sector 1.47

Industry 1.47

Net Debt / EBITDA

11.76

Sector -19.88

Industry -19.88

Net Debt / EBIT

11.65

Sector -160,401,241.42

Industry -160,401,241.42

Net Debt / Equity

-1.00

Sector -0.78

Industry -0.78

Gross Debt / Equity

0.00

Sector -0.52

Industry -0.52

Equity/Assets

0.91

Sector 0.43

Industry 0.43

Liabilities/Assets

0.09

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals QTTB

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Q32 Bio Inc ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$8.10

Fair Value

$13.95

Upside

72.22%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

QTTB - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Q32 Bio Inc

Q32 Bio Inc

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2018

Time since IPO - 8 years

22

Employees

Q32 Bio Inc (United States) is listed on the Nasdaq and has a market capitalization of $165.58 million, with shareholders equity totaling $105.91 million.

The company employs approximately 22 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Q32 Bio Inc reported $- in revenue, generating net income of $33.79 million.

Key financial metrics include a P/E ratio of 4.90, a price-to-book (P/B) ratio of 1.56, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker QTTB.

Market cap

$165.58 million

Net worth

$105.91 million

$105,905,000.00

Assets

$115.87 million

$115,867,000.00

Total Shares Outstanding

20.34 million

20,342,000

Average Daily Trading Volume

$757.92 Thousand

$757,924.76

Sector

Others

Industry

Others

QTTB

QTTB revenue and profits

Financial Results QTTB

DRAG THE FRAME TO SEE MORE DATA

QTTB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$379.23 8,55% (12M)

P/E

24.07

2.40%

ROE

13.51%

P/BV

3.25

SHEL - Shell PLC ADR

$102.57 47,58% (12M)

P/E

10.82

3.01%

ROE

14.29%

P/BV

1.55

STLA - Stellantis NV

$4.43 --56,49% (12M)

P/E

-0.51

0.00%

ROE

-35.93%

P/BV

0.18

COR - Cencora Inc.

$330.14 4,94% (12M)

P/E

23.65

0.75%

ROE

81.03%

P/BV

19.16

ALIZY - Allianz SE ADR

$47.34 --19,01% (12M)

P/E

12.88

2.91%

ROE

17.89%

P/BV

2.30

TTE - TotalEnergies SE ADR

$88.71 64,04% (12M)

P/E

6.98

4.69%

ROE

21.42%

P/BV

1.50

NSRGY - Nestle SA ADR

$92.64 3,14% (12M)

P/E

10.97

4.38%

ROE

58.05%

P/BV

6.37

ELV - Elevance Health Inc

$426.67 23,81% (12M)

P/E

20.49

1.65%

ROE

9.84%

P/BV

2.02